Viewing Study NCT04528992


Ignite Creation Date: 2025-12-24 @ 3:34 PM
Ignite Modification Date: 2025-12-24 @ 3:34 PM
Study NCT ID: NCT04528992
Status: WITHDRAWN
Last Update Posted: 2024-11-25
First Post: 2020-08-18
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Effects of Blood Flow Restriction (BFR) Therapy on ACL Graft Maturation
Sponsor: Stanford University
Organization:

Study Overview

Official Title: Effects of Blood Flow Restriction (BFR) Therapy on Early Anterior Cruciate Ligament (ACL) Graft Maturation
Status: WITHDRAWN
Status Verified Date: 2024-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: BFR Physical Therapy Protocol was not finalized and department had multiple similar studies.
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a study comparing the effects of blood flow restriction (BFR) therapy on the maturation of the Anterior Cruciate Ligament (ACL) graft after reconstruction surgery compared to physical therapy without the use of BFR.
Detailed Description: The study will be a randomized controlled trial to compare outcomes between physical therapy with BFR and physical therapy without BFR on the ACL graft maturation following reconstruction surgery. BFR therapy will begin as early as 2 weeks after surgery. The initial 2 weeks after surgery, or prior to initiation of BFR, will consist of the physical therapy following the surgeon's postoperative protocol.

To be considered for participation in this study, patients must be 18 years and older undergoing primary ACL reconstruction. In addition, patients must meet several inclusion/exclusion criteria to be randomized and included in this study.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: